AMAG Shares Outstanding History
Below is a table of the AMAG shares outstanding history going back to 2/16/2010:

Date AMAG Shares Outstanding
2/16/201020.99M
5/3/201021.01M
8/2/201021.05M
11/1/201021.12M
2/16/201121.14M
5/2/201121.16M
7/29/201121.19M
11/2/201121.20M
2/16/201221.35M
4/27/201221.36M
7/30/201221.39M
10/31/201221.42M
2/15/201321.54M
4/25/201321.57M
7/31/201321.69M
10/31/201321.74M
2/3/201421.80M
4/29/201421.92M
7/31/201421.96M
10/31/201422.09M
2/4/201525.62M
5/1/201530.53M
7/22/201530.93M
11/2/201534.70M
2/12/201634.75M
5/2/201634.58M
8/4/201634.15M
10/31/201634.21M
2/13/201734.34M
4/28/201735.05M
7/31/201735.29M
10/31/201735.37M
2/27/201834.09M
5/1/201834.33M
7/30/201834.47M
10/29/201834.54M
12/18/201834.61M
2/25/201934.71M
5/3/201933.77M
8/1/201933.90M
8/2/20198.73M
10/28/201933.92M
3/2/202034.27M
5/6/202034.27M
8/12/202034.48M
11/4/202034.73M

Also see: AMAG Market Cap History
AMAG YTD Return
AMAG Historical Shares Outstanding:
+4.81% CAGR
AMAG Historical Shares Outstanding: +4.81% CAGR

Mouse over chart for data details
2/16/2010 ...11/4/2020
AMAG Pharmaceuticals is a pharmaceutical company focused on product candidates across a range of therapeutic areas. Co.'s products support the health of patients in the areas of hematology and maternal and women's health, including Feraheme® (ferumoxytol injection) for intravenous use, Makena® (hydroxyprogesterone caproate injection) auto-injector, Intrarosa® (prasterone) vaginal inserts and Vyleesi® (bremelanotide injection). In addition to its approved products, Co.'s portfolio includes two product candidates, AMAG-423 (digoxin immune fab (ovine)), which is being studied for the treatment of severe preeclampsia, and ciraparantag, which is being studied as an anticoagulant reversal agent. We show 46 historical shares outstanding datapoints in our coverage of AMAG's shares outstanding history.

Understanding the changing numbers of AMAG shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AMAG versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AMAG by allowing them to research AMAG shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree AMAG Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AMAG Pharmaceuticals (AMAG) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

AMDA Shares Outstanding History
AMED Shares Outstanding History
AMEH Shares Outstanding History
AMGN Shares Outstanding History
AMN Shares Outstanding History
AMPH Shares Outstanding History
AMRX Shares Outstanding History
AMTI Shares Outstanding History
ANAB Shares Outstanding History
ANAC Shares Outstanding History
More Healthcare companies »

 

AMAG Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.